Argus Research Upgrades UnitedHealth Group to Buy, Announces $400 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 56.4%

Neg 0% Neu 56.4% Pos 0%

Argus Research analyst David Toung upgrades UnitedHealth Group (NYSE:UNH) from Hold to Buy and announces $400 price target.